NEWELL WILLIAM J (CEO & President) exercised options at SUTRO BIOPHARMA, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 1/31/2023ACC: 0001209191-23-005765
DirectorOfficer· CEO & President
Since Sep 2018
-5.60K
Net shares
Net seller
$42.0K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
13.75K acquired · 19.35K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+13.75K
Price / share
—
Trade value
—
% of position
11.1%
1/27/2023
124.04K→137.79K
Common Stock
Direct
Shares
−5.60K
Price / share
$7.50
Trade value
$42K
% of position
4.1%
1/27/2023
137.79K→132.19K
Total
Net shares
+8.15K
Net value
-$42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/27/2023 | M · Option Exercise | +13.75K | — | — | 11.1% | 124.04K | 137.79K |
| Common Stock Direct | 1/27/2023 | F · Tax Withholding | −5.60K | $7.50 | $42K | 4.1% | 137.79K | 132.19K |
| Total | +8.15K | -$42K | ||||||
Derivative Transactions1
Restricted Stock Unit (RSU)
Direct
Converts to
Common Stock
13.75K shares
Shares
−13.75K
Strike price
Held after
13.75K
Exercisable
—
1/27/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit (RSU) Direct | Common Stock13.75K shares | 1/27/2023 | M · Option Exercise | −13.75K | — | 13.75K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned116.53K
Total
116.53K indirect116.53K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 116.53K | Indirect |
| Total | 116.53K | 116.53K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported